ABSTRACT -This study investigated the deleterious effects of the synthetic non-steroidal estrogen diethylstilbestrol (DES) on testicular Leydig cells and compared these effects with those of the natural estrogen 17β-estradiol (E2). For that purpose, we performed microarray analysis of a mouse Leydig cell line (TTE1) treated with these estrogens, followed by Gene Ontology (GO) analysis and parametric analysis of gene set enrichment (PAGE). Most notably, GO analysis revealed a significant decrease in the biological processes of the GO categories "DNA repair" and "apoptotic program" in DES-exposed cells. PAGE showed that "cell death," which is a superior GO category including apoptosis in the GO tree structure, significantly decreased in DES-exposed cells but significantly increased in E2-exposed cells. Interestingly, only 2 genes (Tia1 and Gas1) with altered expression patterns in the "cell death" category were common between DES-and E2-treated cells. The downregulation of apoptotic cell death pathways and DNA repair capability of DES-exposed cells implies that DES promotes carcinogenic processes more strongly than E2 does. These findings suggest that molecular events that occur following DES and E2 treatments differ substantially in Leydig cells, and that the effects of synthetic estrogen and natural estrogen differ more substantially than previously suspected.
INTRODUCTION
Because testicular Leydig cells express estrogen receptors (ERs) (Fisher et al., 1997; Saunders et al., 1998) , estrogens and estrogenic agents have adverse effects on Leydig cells, such as reduced testicular steroidogenesis (Haavisto et al., 2001; Houk et al., 2004) , structural and functional abnormalities (Warita et al., 2006 (Warita et al., , 2008 Nakamura et al., 2010) , and carcinogenic activities (Kurland et al., 1975; Reznik-Schüller, 1979; Deshmukh and Hartung, 1983; Fowler et al., 2000) . Diethylstilbestrol (DES) is a synthetic compound with potent estrogenic activity and is generally believed to bind to ERs and mimic the action of the natural estrogen 17β-estradiol (E2). We have previously shown that DES causes epigenetic alteration related to the acetylated histone H3 in steroidogenic genes of Leydig cells, and that E2 does not cause such an alteration (Warita et al., 2010) . In the rat prostate, it is reported that DES and E2 treatments induce unique and/or alteration of common cellular processes, which may be linked to dysplasia development specific to both DES and E2 (Tam et al., 2008) . These findings suggest that synthetic and natural estrogens affect estrogenreactive cells through different molecular mechanisms, although both the ligands have the same ERs.
DNA microarray assays enable us to simultaneously profile the expression of many thousands of genes in cells and offer the opportunity to gain insight into various biological responses. An exhaustive analysis of changes occurring in gene expression profiles can be very useful; however, for understanding biological significance, it is necessary to translate the information obtained from individual genes into a broader characterization by using systematic functional annotation. Gene Ontology (GO) analysis (Ashburner et al., 2000) includes 3 independent ontologies -biological process, molecular function, and cellular component -which enable us to biologically annotate altered genes. We considered that GO-based mapping of gene expression changes could provide an understanding of the comprehensive biological events that were induced in Leydig cells by DES and E2 individually. In the present study, using comprehensive bioinformatic analysis, we investigated the molecular-level changes in DES-and E2-exposed Leydig cells and the differences between these, with particular emphasis on the adverse effects of DES. Our results provide insight into the differences between the effects of synthetic estrogen and natural estrogen, from a toxicological standpoint, on Leydig cells.
MATERIALS AND METHODS

Cell culture and incubation of TTE1 cells with DES and E2
TTE1 cells (Ohta et al., 2002) were used as a Leydig cell model and were cultured as described previously (Warita et al., 2010) . DES (Sigma-Aldrich Corp., St. Louis, MO, USA) was dissolved in dimethyl sulfoxide (DMSO; final concentration, 0.1%) to a final concentration of 5 μM. This dose of DES (5 μM) was shown to induce epigenetic alteration accompanying histone deacetylation in the cholesterol side-chain cleavage enzyme (P450scc) gene (Warita et al., 2010) and was therefore used due to its ability to cause obvious genotoxicity in TTE1 cells. The vehicle DMSO (0.1%) was not toxic to the TTE1 cells and had no effect on cell survival or ability to divide. The cells were cultured in phenol-red-free minimum essential medium alpha (MEMα; Invitrogen-Gibco, Carlsbad, CA, USA) supplemented with 0.5% charcoal-stripped fetal bovine serum (FBS; Biowest, Nuaille, France) for 24 hr at 33°C; this was followed by incubation in phenol-red-free MEMα supplemented with 0.5% charcoal-stripped FBS and DES for 24 hr at 33°C. TTE1 cells treated with 0.1% DMSO served as the control, and each exposure experiment was performed in 3 replicate wells. For determining whether synthetic and natural estrogens have different effects on Leydig cells, we also treated the cells with 5 μM E2 (Wako Pure Chemical, Osaka, Japan), which has approximately the same potency as DES in a yeast two-hybrid assay (Nishihara et al., 2000) , under the same conditions as those used for the DES-exposure experiment.
Separation of total RNA
Total cellular RNA was extracted from cultured TTE1 cells by using an RNeasy total RNA extraction kit (Qiagen, Hilden, Germany). RNA samples were subsequently treated with RNase-free DNase (Qiagen) to eliminate genomic DNA contamination.
Microarray experiment
Microarray analysis was performed as previously described (Tabuchi et al., 2006) . Gene expression was analyzed using a GeneChip system with the Mouse Expression Array 430A that was spotted with 22 690 probe sets (Affymetrix, Santa Clara, CA, USA; http:// www.affymetrix.com/index.affx). Sample preparation for array hybridization was carried out according to the manufacturer's instructions. In brief, 5 μg of total RNA was used to synthesize double-stranded cDNA with the GeneChip expression 3'-amplification reagents one-cycle cDNA synthesis kit (Affymetrix). Biotin-labeled cRNA was then synthesized from the cDNA by using GeneChip expression 3'-amplification reagents for IVT labeling (Affymetrix). After fragmentation, the biotinylated cRNA was hybridized to arrays at 45°C for 16 hr. The arrays were washed, stained with streptavidin-phycoerythrin, and scanned with a probe array scanner (Affymetrix). The scanned chip was analyzed using GeneChip Analysis Suite software (Affymetrix). A representative signal value and detection P value for each probe set were calculated with the Microarray Suite version 5 algorithm (MAS5; Affymetrix).
Analysis of gene expression profiles
Data were imported into the GeneSpring software, version GX7.3.1 (Agilent, Santa Clara, CA, USA), and the following normalizations were applied: data transformation set measurements < 0.01 to 0.01 and per-chip normalization (total chip normalization to the 50th percentile). GeneChip control probes designed by Affymetrix, which are denoted by IDs containing AFFX-, were eliminated from all probes. Flags (present, marginal, or absent) were assigned by Affymetrix treatment of the arrays. A value of P > 0.06 indicated that the gene was not detected at a level significantly different from the background and was thus designated as absent; a value of P between 0.06 and 0.04 resulted in a designation of marginal, and a value of P < 0.04 indicated that the gene was present. This procedure facilitated the elimination of transcripts with very low signals. We extracted those genes whose expression levels differed between the DES-or E2-treated cells and the control. Welch's t-test was used to compare the gene expression levels between the DES-or E2-treated cells and the control, and P values < 0.05 were considered statistically significant.
Gene annotations for the Affymetrix platforms (MOE430A 2.0) were obtained from the AffymetrixNetAffx TM Analysis Center (http://www.affymetrix.com/ analysis/index.affx), NCBI Entrez Gene (http://www. ncbi.nlm.nih.gov/sites/entrez?db=gene), and GO (http:// www.geneontology.org/index.shtml). To identify significantly overrepresented GO terms in the biological process categories, Fisher's exact test was performed using the GeneSpring GO browser tool, which iterates over all GO terms. P values < 0.05 were considered statistically significant.
To detect significant differences at the level of functional categories, we performed parametric analysis of gene set enrichment (PAGE) as reported by Kim and Volsky (2005) . This test was implemented by calculating a Z score for each gene set, which measures the deviation of the average log-ratio for genes in the category from the genome-wide average, in units of the standard deviation (SD). The Z score for each category was calculated as follows:
where μ and σ represent the mean and SD, respectively, of the total fold change (FC) values of quality-controlled genes in a given microarray data set, x is the mean of the FC values of genes for a given gene set, and n is the size of a given gene set. The predefined gene sets were created from the GO category "cell death." We used Microsoft Excel 2007 (Microsoft Corp., Redmond, WA, USA) to obtain the Z scores and the corresponding P values.
Venn diagram generation
Multiple Venn diagrams, based on entire genes and the GO category "cell death," were constructed to show genes that were either significantly upregulated (P < 0.05) or significantly downregulated (P < 0.05) when DES-or E2-treated cells were compared with the control cells.
RESULTS
Gene expression profile by microarray technology
Exhaustive analyses using DNA microarrays that contain 22 690 different probe sets showed striking differences in the gene expression profiles of the DES-and E2-treated cells compared to those of the control cells. Numbers of altered genes were summarized in a Venn diagram ( Fig. 1) . When only genes with significantly different expression levels (P < 0.05) were selected, 409 probe sets were identified with significant differential expression levels between the DES-treated cells and the controls. Of these 409 transcripts, 214 were upregulated, and 195 were downregulated in the DES-treated cells compared to the control cells. Analysis of the E2-treated cells resulted in a total of 456 probe sets being identified, with a significant differential expression between these and the control cells. Of these 456 transcripts, 258 were upregulated, and 198 were downregulated in the E2-treated cells compared to the control cells. There were 38 significantly altered common genes between the DES-treated and E2-treated cells. Fig. 1 . Genes that were significantly altered after treatment with 5 μM DES or E2 were clustered into a Venn diagram. There were 409 and 456 significantly altered genes in the DES-and E2-treated cells, respectively, as compared to the controls. Of these, 38 genes were common between the DES-and E2-treated cells, and individual genes that were significantly upregulated (black bold type) or downregulated (gray bold type) were listed. Cnot4 and Slco2a1 gene expressions were significantly decreased in the DES-treated cells and significantly increased in the E2-treated cells. Gene expression levels between the DES-or E2-treated cells and controls were compared using Welch's t-test, and P values < 0.05 were considered statistically significant.
Feature extraction of altered genes by GO
The genes that were differentially expressed between the DES-treated or E2-treated cells and the control cells were subjected to functional clustering according to their GO classification (in the biological process category). Significantly altered common GO categories between the DES-treated and E2-treated cells are shown in Table 1 . Amino acid biosynthesis and pathways related to serine metabolism were the main common GO categories revealing significant upregulation, whereas the shared downregulated GO categories included those related to the cell cycle and posttranslational protein targeting to the membrane. The top 20 GO categories altered only in the DES-and E2-treated cells are listed in Tables 2 and 3 , respectively. In both DES-treated and E2-treated cells, it is noteworthy that GO categories related to metabolic processing of various biological substances were mainly overrepresented in the list of the upregulated and downregulated transcripts; however, target substances were markedly different between the DES-treated and E2-treated cells. Most notably, the GO terms "DNA repair" and "apoptotic program" were detected only in the DES-treated cells as downregulated biological processes (shown in bold in Table 2 ). We focused on these 2 cellular reactions as further analysis objects.
Because the GO categories related to cell death induced by DNA damage decreased in DES-treated cells, we evaluated an altered gene list by using PAGE, particularly with respect to cell death (Table 4) . PAGE revealed that the "cell death" category in the DES-treated cells significantly decreased (P = 0.0016, FC average < 0, compared with controls), whereas that in the E2-treated cells significantly increased (P = 0.0386, FC average > 0, compared with the controls). In addition, "apoptosis" and "regulation of programmed cell death," which are both subcategories of "cell death," were significantly downregulated only in the DES-treated cells compared with controls.
Significant differences in alteration of expression of "cell death" category genes between DES-and E2-treated cells and control cells
We used a Venn diagram to analyze alterations in gene expression in response to DES or E2 at the individual gene level (Fig. 2) . In the category of "cell death," 18 genes with significant differential expression between DES-treated cells and the controls were identified. Of these 18 transcripts, 6 were upregulated, and 12 were downregulated in the DES-treated cells compared to the controls. Regarding the E2-treated cells, 26 genes were identified with a significantly differential expression to that of control cells. Of these 26 transcripts, 14 were upregulated, and 12 were downregulated in the E2-treated cells as compared to the controls. The only significantly upregulated or downregulated genes common between DES-and E2-treated cells were Tia1 and Gas1.
DISCUSSION
Numerous signaling pathways originate at ERs, and it has been suggested that both DES and E2 may have their own individual molecular signaling networks (Tam et al., 2008) . In this study, using the GO classification system, we extracted the profiles of altered gene expression in the DES-treated Leydig cells and compared them with those of the E2-treated cells, with particular emphasis on GO:0006695 cholesterol biosynthesis 3 0.0075 "Genes in list in category" represents the number of altered genes in the GO category. P values less than 0.05 were considered statistically significant (Fisher's exact test) . GO terms are ranked by the number of genes included in "Genes in list in category." Arbitrary significant GO terms focused on in this study are shown in bold. "Genes in list in category" represents the number of altered genes in the GO category. P values less than 0.05 were considered statistically significant (Fisher's exact test) . GO terms are ranked by the number of genes included in "Genes in list in category." the adverse effects of the synthetic non-steroidal estrogen DES. To our knowledge, this is the first study in which DES-and E2-treated Leydig cells have been compared using GO analysis.
Our results indicate that the gene expression profile of the DES-treated cells differed drastically from that of the controls and the E2-treated cells. Overall, GO analyses revealed that metabolic processing of various biological substances was mainly and significantly altered both in the DES-treated and E2-treated cells compared with the controls. Most of the target substances for metabolism were unique to either DES-or E2-treated cells, suggesting that the molecular signaling events induced by DES are markedly different from those induced by E2. GO categories where decreased expression among both the DESand E2-treated cells was detected were "cell cycle" and "mitotic cell cycle". Lassurguère et al. (2003) reported that the proliferation of Leydig cells was inhibited by treatment with 4 × 10 -6 M (4 μM) of DES in vitro. Therefore, our results are in accordance with those of previous studies. Notably, GO analyses revealed that the categories "apoptotic program" and "DNA repair" were significantly decreased only in the DES-treated cells. In the GO classification, "apoptotic program" is a subcategory of "cell death" and refers to a form of programmed cell death. It has been reported that exposure to DES induces germinal cell apoptosis in male rodents (Nonclercq et al., 1996; Nair and Shaha, 2003; Ma et al., 2008) ; however, our results suggest that DES provides Leydig cells with an intracellular environment in which it is difficult to trigger apoptosis. Meanwhile, "DNA repair" is a subcategory of "DNA metabolism," which is the high-ranked GO term decreased in the DES-treated cells. DuMond and Roy (2001) have previously demonstrated that the DNA repair capability of Leydig cells is inhibited by exposure to DES. Our findings, from the perspective of GO analysis, are consistent with these findings. Exposure of Syrian hamsters to DES inhibits the mRNA expression level of DNA polymerase β (Roy et al., 1997) . Any reduction in the formation of DNA polymerase β would result in a reduction of DNA repair capability, because this protein is known to play an important role in the DNA repair system; hence, DES may inhibit the DNA repair system directly through DNA repair gene regulation.
PAGE is a useful microarray analysis method (Kim and Volsky, 2005) . It is statistically sensitive and requires less computation than many other programs do. It can identify biological themes that are significantly changed from a microarray dataset, irrespective of the microarray data analysis methods or microarray platforms used, and it is useful for comparing multiple microarray datasets. Z test was performed to compare the altered genes in the GO category. FC average values that were significantly changed (P < 0.05) are shown in bold. FC, fold change.
Fig. 2.
Altered genes that were classified into the Gene Ontology (GO) category "cell death." Genes that were significantly upregulated (black bold type) or downregulated (gray bold type) after treatment with DES or E2 were clustered into a Venn diagram. There were 6 significantly upregulated and 12 significantly downregulated genes in the DES-treated cells as compared to the controls. In the E2-treated cells, there were 14 significantly upregulated and 12 significantly downregulated genes as compared to the controls. The only significantly up-or downregulated genes in common between the DES-and E2-treated cells were Tia1 and Gas1. Gene expression levels between the DES-or E2-treated cells and controls were compared using Welch's t-test, and P values < 0.05 were considered statistically significant.
In the present study, gene sets that were derived from GO categories related to cell death were analyzed using PAGE. The GO categories of "apoptosis" and "regulation of programmed cell death," both of which are subcategories of "cell death," were significantly decreased only in the DES-treated cells. These data support the results of the GO analysis in this study and suggest that DES treatment induces a cellular environment that is less susceptible to apoptosis. Interestingly, PAGE showed that DES and E2 had opposite effects on gene expression pathways of cell death in Leydig cells. In fact, the Venn diagram analysis revealed that the expression of genes included in the GO "cell death" category was markedly different between DES-and E2-treated cells. Thus, it is considered that the results of PAGE are likely to reflect this characteristic molecular event.
It has previously been reported that genomic instability or mutation occurs in DES-induced tumors and nontumor tissues in rodents (Singh and Roy, 2008; Singh et al., 2004) . It is well known that DNA damage can disrupt gene expression and cell function, impair transcription, cause cell cycle arrest, and (if the damage is serious) trigger apoptotic cell death (Freitas and de Magalhães, 2011) , which is a mechanism to prevent cancerous transformation. The observed DES-induced DNA damage may have been promoted by loss of DNA repair capability and an intracellular environment that is unfavorable to apoptosis, as detected in our study. If genes important in controlling cell proliferation are impaired by DES and the cells survive without appropriate gene repair and/ or apoptosis, it seems likely that the chances of transformation to tumor cells will increase. Furthermore, DES may induce more potentially carcinogenic activity than E2, because both GO categories associated with apoptosis and DNA repair decreased significantly only in the DES-treated cells. Meanwhile, although the detection of an increase in cell division can be straightforward evidence suggestive of carcinogenesis, the expression of genes related to cell cycle regulation decreased both in the DES-and E2-treated cells in this study. Previous studies have shown that decreased cell division is a characteristic cellular response in Leydig cells exposed to estrogens (Lassurguère et al., 2003) . We consider that this is simply a phenomenon of the early impact of estrogen, because cell division is inhibited before any other event in estrogen-exposed Leydig cells in short-term in vitro experiments such as our study. We also consider that the reduction of apoptotic cell death pathways and DNA repair capability may contribute to carcinogenesis, with accompanying inhibition of cell division.
In summary, we showed consistent and characteristic differences in gene expression patterns between DESand E2-treated Leydig cells. The reduced expression of apoptotic cell death pathways and DNA repair capability of the DES-exposed Leydig cells imply that DES promotes carcinogenic processes more strongly than E2 does. These findings suggest that the deleterious effects of DES and E2 on Leydig cells differ more substantially than what was previously suspected, and that the molecular events induced by synthetic and natural estrogens are significantly different, even though those hormones bind to the same receptors. Our data could serve as a basis for future follow-up investigations.
